News
Novartis found to be in breach of code over drug brochure
BMJ 2013; 346 doi: https://doi.org/10.1136/bmj.f4061 (Published 21 June 2013) Cite this as: BMJ 2013;346:f4061
- Jacqui Wise
- 1London
Novartis has been found to have made several breaches of the drug advertising code of practice over a brochure promoting a new drug for chronic obstructive pulmonary disease (COPD).1
The Drug and Therapeutics Bulletin made several specific complaints about the evidence used and the claims made in …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £157 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£30 / $37 / €33 (excludes VAT)
You can download a PDF version for your personal record.